The molecular mechanisms of signal pathway activating effect of E2F-1/NF-κB/GSK-3β on cognitive dysfunction of Alzheimer rats

References

• Mantzavinos V, Alexiou A. Biomarkers for Alzheimer’s disease diagnosis. Curr Alzheimer Res. 2017;14(11):1149–1154. PMID: 28164766; PMCID: PMC5684784.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. 2016 Alzheimer’s disease facts and figures. Alzheimers Dement. 2016 Apr;12(4):459–509. PMID: 27570871.
   PubMedGoogle Scholar
• Soria Lopez JA, González HM, Léger GC. Alzheimer’s disease. Handb Clin Neurol. 2019;167:231–255. PMID: 31753135.
   PubMedGoogle Scholar
• Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018 Apr;14(4):483–491. Epub 2018 Feb 9. PMID: 29433981.
   PubMed Web of Science ®Google Scholar
• Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res. 2018 Jul 31;7:F1000Faculty Rev–1161. PMID: 30135715; PMCID: PMC6073093.
   Google Scholar
• Zhang H, Zheng Y. β amyloid hypothesis in Alzheimer’s disease: pathogenesis, prevention, and management. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Oct 30;41(5):702–708. Chinese. PMID: 31699204.
   PubMedGoogle Scholar
• Naseri NN, Wang H, Guo J, et al. The complexity of tau in Alzheimer’s disease. Neurosci Lett. 2019 Jul 13;705:183–194. Epub 2019 Apr 25. PMID: 31028844; PMCID: PMC7060758.
   PubMed Web of Science ®Google Scholar
• Forloni G. Balducci C. Alzheimer’s disease, oligomers, and inflammation. J Alzheimers Dis. 2018;62(3):1261–1276. PMID: 29562537; PMCID: PMC5869993.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang NQ, Yan F, et al. Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link. Behav Brain Res. 2018 Feb 26;339:57–65. Epub 2017 Nov 21. PMID: 29158110.
   PubMed Web of Science ®Google Scholar
• Hernandez F, Lucas JJ, Avila J. GSK3 and tau: two convergence points in Alzheimer’s disease. J Alzheimers Dis. 2013;33(Suppl 1):S141–4. PMID: 22710914.
   PubMed Web of Science ®Google Scholar
• Li H, Liu Y, Tian D, et al. Overview of cannabidiol (CBD) and its analogues: structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease. Eur J Med Chem. 2020 Apr 15;192:112163. Epub 2020 Feb 22. PMID: 32109623.
   PubMed Web of Science ®Google Scholar
• Seo EJ, Fischer N, Efferth T. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease. Pharmacol Res. 2018 Mar; 129: 262–273 Epub 2017 Nov 24. PMID: 29179999
   PubMed Web of Science ®Google Scholar
• Sajan FD, Martiniuk F, Marcus DL, et al. Apoptotic gene expression in Alzheimer’s disease hippocampal tissue. Am J Alzheimers Dis Other Demen. 2007 Aug-Sep;22(4):319–328. PMID: 17712163.
   PubMedGoogle Scholar
• Du Y, Liu X, Zhu X, et al. Activating transcription factor 6 reduces Aβ1-42 and restores memory in Alzheimer’s disease model mice. Int J Neurosci. 2020 Oct;130(10):1015–1023. Epub 2020 Jan 21. PMID: 31928492.
   PubMed Web of Science ®Google Scholar
• Bromley-Brits K, Deng Y, Song W. Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp. 2011 Jul 20;53:2920. PMID: 21808223; PMCID: PMC3347885.
   Google Scholar
• Bondi MW, Edmonds EC, Salmon DP. Alzheimer’s disease: past, present, and future. J Int Neuropsychol Soc. 2017 Oct;23(9–10):818–831. PMID: 29198280; PMCID: PMC5830188.
   PubMed Web of Science ®Google Scholar
• Atri A. The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am. 2019 Mar;103(2):263–293. PMID: 30704681.
   PubMed Web of Science ®Google Scholar
• Jack CR Jr, Bennett DA, Blennow K, et al.; Contributors. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018 Apr;14(4):535–562. PMID: 29653606; PMCID: PMC5958625.
   PubMed Web of Science ®Google Scholar
• Dunn AR, KMS O, Kaczorowski CC. Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease. Neurosci Biobehav Rev. 2019 Aug; 103:73–80. Epub 2019 Jun 14. PMID: 31207254; PMCID: PMC6700747.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Arain HA, Stecker MM, et al. Amyloid toxicity in Alzheimer’s disease. Rev Neurosci. 2018 Aug 28;29(6):613–627. PMID: 29447116.
   PubMed Web of Science ®Google Scholar
• Li Q, Liu Y, Sun M. Autophagy and Alzheimer’s disease. Cell Mol Neurobiol. 2017 Apr 3;37:377–388. Epub 2016 Jun 3. PMID: 27260250.
   PubMed Web of Science ®Google Scholar
• Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, et al. Mouse models of Alzheimer’s disease. J Alzheimers Dis. 2017;57(4):1171–1183. PMID: 28304309.
   PubMed Web of Science ®Google Scholar
• Zakaria R, Wan Yaacob WM, Othman Z, et al. Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer’s disease. Physiol Res. 2017 Sep 22;66(4):553–565. Epub 2017 Apr 12. PMID: 28406691.
   PubMed Web of Science ®Google Scholar
• Karthick C, Nithiyanandan S, Essa MM, et al. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer’s disease. Neurol Res. 2019 Feb;41(2):139–150. Epub 2018 Nov 19. PMID: 30453864.
   PubMed Web of Science ®Google Scholar
• Du Q, Zhu X, Si J. Angelica polysaccharide ameliorates memory impairment in Alzheimer’s disease rat through activating BDNF/TrkB/CREB pathway. Exp Biol Med (Maywood). 2020 Jan;245(1):1–10. Epub 2019 Dec 17. PMID: 31847588; PMCID: PMC6987749.
   PubMed Web of Science ®Google Scholar
• Jouanne M, Rault S, Voisin-Chiret AS. Tau protein aggregation in Alzheimer’s disease: an attractive target for the development of novel therapeutic agents. Eur J Med Chem. 2017 Oct 20;139:153–167. Epub 2017 Jul 29. PMID: 28800454.
   PubMed Web of Science ®Google Scholar
• Luna-Muñoz J, García-Sierra F, Falcón V, et al. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer’s disease. J Alzheimers Dis. 2005 Sep 8;8(1):29–41. PMID: 16155347.
   PubMed Web of Science ®Google Scholar
• Naqvi AAT, Jairajpuri DS, Noman OMA, et al. Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: towards therapeutic management of Alzheimer’s disease. J Biomol Struct Dyn. 2020 Aug;38(13):3892–3907. Epub 2019 Sep 25. PMID: 31512980.
   PubMed Web of Science ®Google Scholar
• Yang SD, Song JS, Yu JS, et al. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer’s disease brain. J Neurochem. 1993 Nov;61(5):1742–1747. PMID: 8228990.
   PubMed Web of Science ®Google Scholar
• Yang W, Liu Y, Xu QQ, et al. Sulforaphene ameliorates neuroinflammation and hyperphosphorylated Tau protein via regulating the PI3K/Akt/GSK-3β pathway in experimental models of Alzheimer’s disease. Oxid Med Cell Longev. 2020 Sep 10;2020:4754195. PMID: 32963694; PMCID: PMC7502131.
   PubMed Web of Science ®Google Scholar
• Ochalek A, Mihalik B, Avci HX, et al. Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation. Alzheimers Res Ther. 2017 Dec 1;9(1):90. PMID: 29191219; PMCID: PMC5709977.
   PubMed Web of Science ®Google Scholar
• Chiroma SM, Baharuldin MTH, Mat Taib CN, et al. Centella asiatica protects d-galactose/AlCl3 mediated Alzheimer’s disease-like rats via PP2A/GSK-3β signaling pathway in their hippocampus. Int J Mol Sci. 2019 Apr 16;20(8):1871. PMID: 31014012; PMCID: PMC6514756.
   PubMed Web of Science ®Google Scholar
• Tönnies E, Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. J Alzheimers Dis. 2017;57(4):1105–1121. PMID: 28059794; PMCID: PMC5409043.
   PubMed Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 2018 Apr; 14:450–464 Epub 2017 Oct 18. PMID: 29080524; PMCID: PMC5680523
   PubMed Web of Science ®Google Scholar
• Zhang YH, Wang DW, Xu SF, et al. α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice. Redox Biol. 2018 Apr; 14:535–548 Epub 2017 Nov 7. PMID: 29126071; PMCID: PMC5684493
   PubMed Web of Science ®Google Scholar
• Lei Q, Yi T, Chen C. NF-κB-Gasdermin D (GSDMD) axis couples oxidative stress and NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome-mediated cardiomyocyte pyroptosis following myocardial infarction. Med Sci Monit. 2018 Aug 30;24:6044–6052. PMID: 30161099; PMCID: PMC6128186.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song X, Herrup K. Context-dependent functions of E2F1: cell cycle, cell death, and DNA damage repair in cortical neurons. Mol Neurobiol. 2020 May;57(5):2377–2390. Epub 2020 Feb 15. PMID: 32062842.
   PubMed Web of Science ®Google Scholar